Wenger Vieli advised Xeltis on the deal. Xeltis is a pioneering medtech firm developing medical devices enabling cardiovascular restoration. The Swiss/Dutch university spin-off landed a €15…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now